
Vivalyx
Developer of Omnisol, an investigational perfusion solution for preserving donor organs
- Soha
- Biotech, MedTech
- Tashkil etilgan
- 2022
- Joylashuv
- Germany
Tasdiqlangan daromad: hali ulanmagan
Vivalyx sizningmi? Ushbu sahifani soʻrang va Stripe, App Store yoki Google Play’ni ulang: MRR va oʻsishingiz shu yerda toʻgʻridan-toʻgʻri manbadan koʻrinadi.
Startap haqida
Vivalyx develops Omnisol, a blood-replacing perfusion solution designed to preserve and revitalise donor organs for transplantation. Omnisol is investigational and has entered first-in-human clinical use. The company is based in Aachen, Germany and is backed by Armenia-based Granatus Ventures.
Jamoa
- Andreas Schumacher, Co-founder and CEO (Asoschi)
- Benedict Doorschodt, Co-founder and CTO (Asoschi)
- René Tolba, Co-founder and CMO (Asoschi)
- Christian Bleilevens, Co-founder and CSO (Asoschi)
- Malte Brettel, Co-founder (Asoschi)
- Marius Rosenberg, Co-founder (Asoschi)
Auditoriya
Ijtimoiy tarmoqlardagi kuzatuvchilar
Profil maʼlumotlari manbasi: Stanbase.